Daily oral PrEP reaches maximum protective drug levels in about 7 days for receptive anal sex and about 21 days for receptive vaginal sex or injection drug use. These timelines reflect how long the medication takes to build up in different body tissues, so the answer depends on how you’re exposed to HIV.
7 Days for Receptive Anal Sex
The active drug in oral PrEP, tenofovir, accumulates inside cells as a protective compound called tenofovir diphosphate. In rectal tissue, those intracellular levels reach their maximum after about 7 days of daily dosing. The CDC recommends that people starting daily oral PrEP wait approximately 7 days before having condomless receptive anal sex.
Rectal tissue absorbs tenofovir relatively quickly compared to other tissues. The lining of the rectum has a high concentration of the immune cells that HIV targets, and the drug saturates those cells faster there than almost anywhere else in the body. This is why the waiting period is shorter for anal sex than for other routes of exposure.
21 Days for Vaginal Sex and Injection Drug Use
Cervicovaginal tissue takes significantly longer to reach protective drug levels: approximately 20 to 21 days of consistent daily dosing. The same 21-day timeline applies to people using PrEP to reduce risk from sharing injection equipment.
The difference comes down to biology. Vaginal tissue absorbs and retains tenofovir more slowly than rectal tissue. The drug distributes through the genital tract at lower concentrations relative to what’s circulating in the blood, and it simply takes longer to build up enough of the active compound inside cells to block HIV from establishing an infection. If you’re taking PrEP primarily for vaginal sex, plan on three full weeks of daily pills before relying on it as your main form of protection.
No Clear Timeline for Insertive Sex
The CDC notes there are currently no data on how long PrEP takes to reach protective levels for insertive vaginal or insertive anal sex. The 7-day and 21-day figures are based on drug concentrations measured in rectal and cervicovaginal tissue specifically. If your primary risk involves insertive sex, the safest approach is to follow the longer 21-day guideline while using other prevention methods in the meantime.
On-Demand PrEP: The 2-1-1 Schedule
For men who have sex with men, there’s an alternative to daily dosing called event-driven or “on-demand” PrEP. It follows a 2-1-1 schedule: take 2 pills between 2 and 24 hours before sex, then 1 pill 24 hours after that first double dose, and 1 more pill 24 hours later. This approach has been studied only for receptive anal sex and is not recommended for vaginal sex or injection drug use.
The 2-1-1 method means protection can begin as quickly as 2 hours before a planned encounter, which makes it an option for people who don’t have sex frequently enough to justify a daily pill. However, it requires planning ahead and completing all four pills on schedule afterward.
Injectable PrEP Has No Established Onset
Injectable PrEP (sold as Apretude) is a long-acting shot given every two months after two initial monthly doses. Unlike the oral pill, the exact time from the first injection to maximum protection is officially unknown. The FDA label states that the onset timeline has not been determined. People starting injectable PrEP typically begin with a one-month oral lead-in period or are advised to use additional protection in the early weeks after their first shot.
Descovy vs. Truvada
Two oral PrEP pills are available: Truvada (and its generics) and Descovy. Both contain a form of tenofovir, but they use different versions of the drug. Data from the DISCOVER trial suggest that Descovy reaches protective levels somewhat faster and maintains them longer after a missed dose compared to Truvada. In practice, the CDC’s 7-day and 21-day guidelines apply to both medications, but the pharmacologic differences may offer a small additional safety margin with Descovy if adherence isn’t perfect.
Descovy is approved only for people at risk through receptive anal sex, not vaginal sex. Truvada and its generics remain the standard option for anyone whose risk involves vaginal exposure or injection drug use.
Why Consistency Matters
PrEP’s protection depends on maintaining drug levels in the tissues where HIV would enter your body. Those levels build up over days of consistent dosing, and they also drop when you miss pills. If you skip several doses and then restart, you’re essentially back at the beginning of the ramp-up period. The same 7-day or 21-day timeline applies again before you can expect full protection.
Taking your pill at roughly the same time each day keeps tissue concentrations stable. If you do miss a dose, take it as soon as you remember and continue your regular schedule. A single missed dose here and there is unlikely to eliminate protection entirely, but a pattern of missed doses will reduce how well the drug works. During any period of inconsistent use, combining PrEP with condoms significantly lowers your risk.